Epidemiological Evidence for Cardiovascular Disease in HIV-infected Patients and Relationship to Highly Active Antiretroviral Therapy

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2008 Jun 21

PMID 18566319

Citations 158

Authors

Judith S Currier

Jens D Lundgren

Andrew Carr

Daniel Klein

Caroline A Sabin

Paul E Sax

Jeffrey T Schouten

Marek Smieja

Affiliations

Soon will be listed here.

Citing Articles

Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease.

Obare L, Temu T, Mallal S, Wanjalla C Circ Res. 2024; 134(11):1515-1545.

PMID: 38781301 PMC: 11122788. DOI: 10.1161/CIRCRESAHA.124.323891.

Mechanisms and Cardiorenal Complications of Chronic Anemia in People with HIV.

Kamvuma K, Hamooya B, Munsaka S, Masenga S, Kirabo A Viruses. 2024; 16(4).

PMID: 38675885 PMC: 11053456. DOI: 10.3390/v16040542.

Efficacy and effect on lipid profiles of switching to ainuovirine-based regimen versus continuing efavirenz-based regimen in people with HIV-1: 24-week results from a real-world, retrospective, multi-center cohort study.

Wang C, Yu X, Ke Y, Fu Y, Luo Y, Li Y Antimicrob Agents Chemother. 2024; 68(4):e0166823.

PMID: 38483175 PMC: 10989015. DOI: 10.1128/aac.01668-23.

Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study.

Yendewa G, Perez J, Patil N, McComsey G Front Immunol. 2024; 15:1297195.

PMID: 38318191 PMC: 10838972. DOI: 10.3389/fimmu.2024.1297195.

Life course history of physical and sexual abuse is associated with cardiovascular disease risk among women living with and without HIV.

Appleton A, Kuniholm M, Vasquez E, Cohen M, Donohue J, Floris-Moore M AIDS. 2023; 38(5):739-750.

PMID: 38126350 PMC: 10939824. DOI: 10.1097/QAD.0000000000003822.

References

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

Friis-Moller N, Reiss P, Sabin C, Weber R, Monforte A, El-Sadr W . Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17):1723-35. DOI: 10.1056/NEJMoa062744. View

Iloeje U, Yuan Y, Litalien G, Mauskopf J, Holmberg S, Moorman A . Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med. 2005; 6(1):37-44. DOI: 10.1111/j.1468-1293.2005.00265.x. View

Depairon M, Chessex S, Sudre P, Rodondi N, Doser N, Chave J . Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy. AIDS. 2001; 15(3):329-34. DOI: 10.1097/00002030-200102160-00005. View

Vittecoq D, Escaut L, Monsuez J . Vascular complications associated with use of HIV protease inhibitors. Lancet. 1998; 351(9120):1959. DOI: 10.1016/s0140-6736(05)78644-x. View

Thomsen T, McGee D, Davidsen M, Jorgensen T . A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol. 2002; 31(4):817-22. DOI: 10.1093/ije/31.4.817. View

de Saint Martin L, Vandhuick O, Guillo P, Bellein V, Bressollette L, Roudaut N . Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study). Atherosclerosis. 2005; 185(2):361-7. DOI: 10.1016/j.atherosclerosis.2005.06.049. View

Holmberg S, Moorman A, Greenberg A . Trends in rates of myocardial infarction among patients with HIV. N Engl J Med. 2004; 350(7):730-2. DOI: 10.1056/NEJM200402123500719. View

Jerico C, Knobel H, Calvo N, Sorli M, Guelar A, Gimeno-Bayon J . Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke. 2006; 37(3):812-7. DOI: 10.1161/01.STR.0000204037.26797.7f. View

10.

Kaplan R, Kingsley L, Sharrett A, Li X, Lazar J, Tien P . Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis. 2007; 45(8):1074-81. DOI: 10.1086/521935. View

11.

Henry K, Melroe H, Huebsch J, Hermundson J, Levine C, Swensen L . Severe premature coronary artery disease with protease inhibitors. Lancet. 1998; 351(9112):1328. DOI: 10.1016/S0140-6736(05)79053-X. View

12.

Holmberg S, Moorman A, Williamson J, Tong T, Ward D, Wood K . Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet. 2002; 360(9347):1747-8. DOI: 10.1016/S0140-6736(02)11672-2. View

13.

Riddler S, Smit E, Cole S, Li R, Chmiel J, Dobs A . Impact of HIV infection and HAART on serum lipids in men. JAMA. 2003; 289(22):2978-82. DOI: 10.1001/jama.289.22.2978. View

14.

Neumann T, Woiwod T, Neumann A, Ross B, von Birgelen C, Volbracht L . Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differences. Eur J Med Res. 2004; 9(2):55-60. View

15.

Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, Monforte A . Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS. 2003; 17(8):1179-93. DOI: 10.1097/01.aids.0000060358.78202.c1. View

16.

Currier J, Taylor A, Boyd F, Dezii C, Kawabata H, Burtcel B . Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003; 33(4):506-12. DOI: 10.1097/00126334-200308010-00012. View

17.

Joy T, Keogh H, Hadigan C, Lee H, Dolan S, Fitch K . Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era. AIDS. 2007; 21(12):1591-600. PMC: 4393713. DOI: 10.1097/QAD.0b013e32823644ff. View

18.

van Wijk J, de Koning E, Cabezas M, Joven J, Roodt J, Rabelink T . Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol. 2006; 47(6):1117-23. DOI: 10.1016/j.jacc.2005.09.073. View

19.

El-Sadr W, Lundgren J, Neaton J, Gordin F, Abrams D, Arduino R . CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006; 355(22):2283-96. DOI: 10.1056/NEJMoa062360. View

20.

Hsue P, Lo J, Franklin A, Bolger A, Martin J, Deeks S . Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004; 109(13):1603-8. DOI: 10.1161/01.CIR.0000124480.32233.8A. View